# Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

Study · id `cardio:ct-nct05298124` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05298124](<https://clinicaltrials.gov/study/NCT05298124>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05298124

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.

## Technical summary

Registry record NCT05298124. Randomized; no masking; primary purpose treatment. Start 2022-05-26 (actual); primary completion 2028-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 144 participants (planned count; ClinicalTrials.gov record NCT05298124, source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)
- Started: 2022-05-26 (actual) (ClinicalTrials.gov record NCT05298124, source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)
- Primary completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT05298124, source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)
- Completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT05298124, source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT05298124, source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05298124-2026-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
- Acronym: MINOS
- Condition: Cardiogenic Shock
- Condition: Mitral Regurgitation
- Intervention (Device): Transcatheter edge-to-edge repair
- Intervention (Other): Medical therapy
- Lead sponsor: Ottawa Heart Institute Research Corporation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)

## Provenance

Content hash: 7b29b1aa48786d09048a01d11a0e1c94bdf09dba3eef871d2899485faeb0f8fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
